Acta Psychiatr Scand. 2001 Sep;104(3):236-8; discusiion 238-9.

Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.

Source

Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, Ontario, Canada.

Abstract

OBJECTIVE:

The notion that antidepressant treatment-associated hypomania or mania being pharmacologically induced has been challenged. To determine whether selective serotonin reuptake inhibitors (SSRI) induced hypomania is secondary to medication effects, we examined the dose-response relationship of SSRI-induced hypomania in two patients with depressive disorder.

METHOD:

Case study.

RESULT:

Hypomanic symptoms emerged during treatment with sertraline at the dose of 300 mg per day in a 45-year-old male with major depression. Paroxetine treatment at the dose of 80 mg per day induced hypomania in a 37-year-old female with dysthymia and trichitillomania. These patients have no family or personal history of bipolar disorder. Hypomania resolved when sertraline was decreased to 200 mg per day and paroxetine to 40 mg per day. No hypomanic switch was observed during 18-24 months follow-up.

CONCLUSION:

In the absence of risk factors for manic switch, SSRI-induced hypomania may be dose-dependent medication effects.

PMID:: 11531662; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Molecular Biology Databases

SERTRALINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Sertraline-induced hypomania: a genuine side-effect. [Acta Psychiatr Scand. 2003]
Sertraline-induced hypomania: a genuine side-effect.
Mendhekar DN, Gupta D, Girotra V. Acta Psychiatr Scand. 2003 Jul; 108(1):70-4.
Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression. [J Clin Psychiatry. 2002]
Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Miner CM, Brown EB, Gonzales JS, Munir R. J Clin Psychiatry. 2002 Mar; 63(3):232-40.
Antidepressant treatment-associated behavioural expression of hypomania: a case series. [Prog Neuropsychopharmacol Biol...]
Antidepressant treatment-associated behavioural expression of hypomania: a case series.
Ramasubbu R. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov; 28(7):1201-7.
Review A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. [Bipolar Disord. 2004]
Review A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V.
Chun BJ, Dunner DL. Bipolar Disord. 2004 Feb; 6(1):32-42.
Review Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. [J Affect Disord. 2005]
Review Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.
Dunner DL, D'Souza DN, Kajdasz DK, Detke MJ, Russell JM. J Affect Disord. 2005 Jul; 87(1):115-9.

See reviews... See all...

Cited by 3 PubMed Central articles

Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. [Ann Gen Psychiatry. 2007]
Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.
Fountoulakis KN, Vieta E, Siamouli M, Valenti M, Magiria S, Oral T, Fresno D, Giannakopoulos P, Kaprinis GS. Ann Gen Psychiatry. 2007 Oct 9; 6:27. Epub 2007 Oct 9.
Review Treating bipolar disorder. Evidence-based guidelines for family medicine. [Can Fam Physician. 2004]
Review Treating bipolar disorder. Evidence-based guidelines for family medicine.
McIntyre RS, Mancini DA, Lin P, Jordan J. Can Fam Physician. 2004 Mar; 50:388-94.
Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers. [J Psychiatry Neurosci. 2003]
Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.
Won M, Minabe Y, Sekine Y, Takei N, Kondo N, Mori N. J Psychiatry Neurosci. 2003 Mar; 28(2):134-5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Dose-response relationship of selective serotonin reuptake inhibitors treatment-...
Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.
Acta Psychiatr Scand. 2001 Sep ;104(3):236-8; discusiion 238-9.

PubMed
Observation of CP violation in the B(0) meson system.
Observation of CP violation in the B(0) meson system.
Phys Rev Lett. 2001 Aug 27 ;87(9):091801. Epub 2001 Aug 14 .

PubMed
Multiplicity distribution and spectra of negatively charged hadrons in Au+Au col...
Multiplicity distribution and spectra of negatively charged hadrons in Au+Au collisions at square root of (sNN) = 130 GeV.
Phys Rev Lett. 2001 Sep 10 ;87(11):112303. Epub 2001 Aug 23 .

PubMed
HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pom...
HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25.
Virology. 2001 Sep 1 ;287(2):359-70.

PubMed
V-shaped scaffold: a new architectural motif identified in an A x (G x G x G x G...
V-shaped scaffold: a new architectural motif identified in an A x (G x G x G x G) pentad-containing dimeric DNA quadruplex involving stacked G(anti) x G(anti) x G(anti) x G(syn) tetrads.
J Mol Biol. 2001 Aug 31 ;311(5):1063-79.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.

Source

Abstract

OBJECTIVE:

METHOD:

RESULT:

CONCLUSION:

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information